共 50 条
- [32] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer Current Urology Reports, 2016, 17
- [33] PATIENT-REPORTED TOXICITY DURING INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2024, 211 (05): : E993 - E993
- [34] THERMAL INTRAVESICAL CHEMOTHERAPY IN ADJUVANT TREATMENT OF HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER ARCHIVOS ESPANOLES DE UROLOGIA, 2021, 74 (09): : 875 - 882
- [35] EXPLORING A NOVEL SYNERGISTIC INTRAVESICAL ONCOLYTIC VIROTHERAPY FOR TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2022, 207 (05): : E78 - E78
- [39] Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer BMC UROLOGY, 2017, 17 : 114
- [40] Study on the Treatment of non-muscle invasive Bladder Cancer UROLOGE, 2015, 54 (03): : 406 - 408